Edesa Biotech, Inc. (EDSA): Total Liabilities

Annual figures by period end, from SEC filings.

$1.83M
As of 2024-09-30
+6.3%
3-year compound annual growth
+31.8%
5-year compound annual growth
-8.3%
10-year compound annual growth
$10.71M2013-08-31: $10.71M2014-08-31: $6.77M2014-09-30: $4.36M2015-09-30: $2.38M2019-09-30: $461.6K2020-09-30: $1.65M2021-09-30: $1.53M2022-09-30: $2.18M2023-09-30: $1.84M2024-09-30: $1.83M$1.83M
2013-08-31 Total Liabilities (USD) 2024-09-30
Period endedTotal LiabilitiesChange YoYSource filing
2024-09-30$1.83M-0.5%2024-12-13, Balance as of period end
2023-09-30$1.84M-15.7%2024-12-13, Balance as of period end
2022-09-30$2.18M+43.1%2023-12-15, Balance as of period end
2021-09-30$1.53M-7.7%2022-12-16, Balance as of period end
2020-09-30$1.65M+258.3%2021-12-28, Balance as of period end
2019-09-30$461.6Kn/a2020-12-07, Balance as of period end
No annual figure between 2015-09-30 and 2019-09-30.
2015-09-30$2.38M-45.4%2015-12-14, Balance as of period end
2014-09-30$4.36Mn/a2015-12-14, Balance as of period end
2014-08-31$6.77M-36.8%2015-12-14, Balance as of period end
2013-08-31$10.71Mn/a2014-11-21, Balance as of period end